L. Deconinck, A. Dinh, C. Nich, T. Tritz, M. Matt, O. Senard, S. Bessis, T. Bauer, M. Rottman, J. Salomon, F. Bouchand, B. Davido. Efficacy of cotrimoxazole (Sulfamethoxazole-Trimethoprim) as a salvage therapy for the treatment of bone and joint infections (BJIs). PLoS ONE 14 (2019) e0224106. https://doi.org/10.1371/journal.pone.0224106

S.W. Ku, A. Jiamsakul, K. Joshi, M.K.U. Pasayan, A. Widhani, R. Chaiwarith, S. Kiertiburanakul, A. Avihingsanon, P.S. Ly, N. Kumarasamy, C.D. Do, T.P. Merati, K. van Nguyen, A. Kamarulzaman, F. Zhang, M.P. Lee, J.Y. Choi, J. Tanuma, S. Khusuwan, B.L.H. Sim, O.T. Ng, W. Ratanasuwan, J. Ross, W. Wong, P. Ly, V. Khol, F. Zhang, H. Zhao, N. Han, M. Lee, P. Li, W. Lam, Y. Chan, N. Kumarasamy, S. Saghayam, C. Ezhilarasi, S. Pujari, K. Joshi, S. Gaikwad, A. Chitalikar, S. Sangle, V. Mave, I. Marbaniang, D. Wirawan, F. Yuliana, E. Yunihastuti, D. Imran, A. Widhani, J. Tanuma, S. Oka, T. Nishijima, J. Choi, N. S, J. Kim, B. Sim, Y. Gani, N. Rudi, A. Kamarulzaman, S. Syed Omar, S. Ponnampalavanar, I. Azwa, R. Ditangco, M. Pasayan, M. Mationg, W. Wong, S. Ku, P. Wu, O. Ng, P. Lim, L. Lee, Z. Ferdous, A. vihingsanon, S. Gatechompol, P. Phanuphak, C. Phadungphon, S. Kiertiburanakul, A. Phuphuakrat, L. Chumla, N. Sanmeema, R. Chaiwarith, T. Sirisanthana, W. Kotarathititum, J. Praparattanapan, S. Khusuwan, P. Kantipong, P. Kambua, W. Ratanasuwan, R. Sriondee, K. Nguyen, H. Bui, D. Nguyen, D. Nguyen, C. Do, A. Ngo, L. Nguyen, A. Sohn, J. Ross, B. Petersen, D. Cooper, M. Law, A. Jiamsakul, D. Rupasinghe. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV. J Int AIDS Soc 22 (2019) e25264. https://doi.org/10.1002/jia2.25264

B. Khalid, S. Shabir, S. Shabir, A. Fatima, S. Aslam, M.A. Khan, M. Ahsan. Efficacy of short course versus standard course oral co-trimoxazole in the management of children with lower urinary tract infections. The Professional Medical Journal 28 (2021) 344-349. https://doi.org/10.29309/TPMJ/2021.28.03.4615

C. Manyando, E.M. Njunju, U. D’Alessandro, J.P. van geertruyden. Safety and Efficacy of Co-Trimoxazole for Treatment and Prevention of Plasmodium falciparum Malaria: A Systematic Review. PLOS ONE 8 (2013) e56916. https://doi.org/10.1371/journal.pone.0056916

N. Ford, Z. Shubber, J. Jao, E.J. Abrams, L. Frigati, L. Mofenson. Safety of cotrimoxazole in pregnancy: a systematic review and meta-analysis. J Acquir Immune Defic Syndr 66 (2014) 512-521. https://doi.org/10.1097/qai.0000000000000211

C.J. Murray, K.S. Ikuta, F. Sharara, L. Swetschinski, G. Robles Aguilar, A. Gray, C. Han, C. Bisignano, P. Rao, E. Wool, S.C. Johnson, A.J. Browne, M.G. Chipeta, F. Fell, S. Hackett, G. Haines-Woodhouse, B.H. Kashef Hamadani, E.A.P. Kumaran, B. McManigal, R. Agarwal, S. Akech, S. Albertson, J. Amuasi, J. Andrews, A. Aravkin, E. Ashley, F. Bailey, S. Baker, B. Basnyat, A. Bekker, R. Bender, A. Bethou, J. Bielicki, S. Boonkasidecha, J. Bukosia, C. Carvalheiro, C. Castañeda-Orjuela, V. Chansamouth, S. Chaurasia, S. Chiurchiù, F. Chowdhury, A.J. Cook, B. Cooper, T.R. Cressey, E. Criollo-Mora, M. Cunningham, S. Darboe, N.P.J. Day, M. De Luca, K. Dokova, A. Dramowski, S.J. Dunachie, T. Eckmanns, D. Eibach, A. Emami, N. Feasey, N. Fisher-Pearson, K. Forrest, D. Garrett, P. Gastmeier, A.Z. Giref, R.C. Greer, V. Gupta, S. Haller, A. Haselbeck, S.I. Hay, M. Holm, S. Hopkins, K.C. Iregbu, J. Jacobs, D. Jarovsky, F. Javanmardi, M. Khorana, N. Kissoon, E. Kobeissi, T. Kostyanev, F. Krapp, R. Krumkamp, A. Kumar, H.H. Kyu, C. Lim, D. Limmathurotsakul, M.J. Loftus, M. Lunn, J. Ma, N. Mturi, T. Munera-Huertas, P. Musicha, M.M. Mussi-Pinhata, T. Nakamura, R. Nanavati, S. Nangia, P. Newton, C. Ngoun, A. Novotney, D. Nwakanma, C.W. Obiero, A. Olivas-Martinez, P. Olliaro, E. Ooko, E. Ortiz-Brizuela, A.Y. Peleg, C. Perrone, N. Plakkal, A. Ponce-de-Leon, M. Raad, T. Ramdin, A. Riddell, T. Roberts, J.V. Robotham, A. Roca, K.E. Rudd, N. Russell, J. Schnall, J.A.G. Scott, M. Shivamallappa, J. Sifuentes-Osornio, N. Steenkeste, A.J. Stewardson, T. Stoeva, N. Tasak, A. Thaiprakong, G. Thwaites, C. Turner, P. Turner, H.R. van Doorn, S. Velaphi, A. Vongpradith, H. Vu, T. Walsh, S. Waner, T. Wangrangsimakul, T. Wozniak, P. Zheng, B. Sartorius, A.D. Lopez, A. Stergachis, C. Moore, C. Dolecek, M. Naghavi. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 399 (2022) 629-655. https://doi.org/10.1016/s0140-6736(21)02724-0

A.K. Sugianli, F. Ginting, I. Parwati, M.D. de Jong, F. van Leth, C. Schultsz. Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review. JAC Antimicrob Resist 3 (2021) dlab003. https://doi.org/10.1093/jacamr/dlab003

M.S. Al-Mogbel, G.A. Menezes, M.T. Elabbasy, M.M. Alkhulaifi, A. Hossain, M.A. Khan. Effect of Synergistic Action of Bovine Lactoferrin with Antibiotics on Drug Resistant Bacterial Pathogens. Medicina 57 (2021) 343. https://doi.org/10.3390/medicina57040343

D.B. Kell, E.L. Heyden, E. Pretorius. The Biology of Lactoferrin, an Iron-Binding Protein That Can Help Defend Against Viruses and Bacteria. Front. Immunol 11 (2020) 1221. https://doi.org/10.3389/fimmu.2020.01221

R. Russo, E. Karadja, F. de Seta. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial. Beneficial Microbes 10 (2019) 19-26. https://doi.org/10.3920/BM2018.0075

P.W. Chen, T.T. Jheng, C.L. Shyu, F.C. Mao. Synergistic antibacterial efficacies of the combination of bovine lactoferrin or its hydrolysate with probiotic secretion in curbing the growth of meticillin-resistant Staphylococcus aureus. J Med Microbiol 62 (2013) 1845-1851. https://doi.org/10.1099/jmm.0.052639-0

A.F.G. Cicero, A. Colletti. Nutraceuticals Active on Immune System. Handbook of Nutraceuticals for Clinical Use (2018) 163–179. https://doi.org/10.1007/978-3-319-73642-6_13

Lactoferrin Market Size & Share Report, 2021-2028. https://www.grandviewresearch.com/industry-analysis/lactoferrin-market (accessed December 28, 2023).

N. Anand, R.K. Kanwar, M.L. Dubey, R.K. Vahishta, R. Sehgal, A.K. Verma, J.R. Kanwar. Effect of lactoferrin protein on red blood cells and macrophages: mechanism of parasite–host interaction. Drug Design, Drug Des Devel Ther. 9 (2015) 3821-3835. https://doi.org/10.2147/dddt.s77860

D. Türk, N. Hanke, T. Lehr. A Physiologically-Based Pharmacokinetic Model of Trimethoprim for MATE1, OCT1, OCT2, and CYP2C8 Drug-Drug-Gene Interaction Predictions. Pharmaceutics 12 (2020) 1074. https://doi.org/10.3390/pharmaceutics12111074

D. Notario, J. Amelia, G. Della. Pengembangan dan Validasi Metode Bioanalisis Trimetoprim dalam Sampel Plasma dan Urin Manusia Simulasi Menggunakan KCKT-PDA. The Indonesian Pharmaceutical Journal 13 (2023) 41-49. https://doi.org/10.22435/jki.v13i1.6189

D. Notario, A. Suwita, K. Kelviyana. Analytical Method Validation of Sulfamethoxazole in Human Plasma and Urine by HPLC-PDA. J. Sains. Kes. 4 (2022) 31-38. https://doi.org/10.25026/jsk.v4iSE-1.1687

M. Fidler, J.J. Wilkins, R. Hooijmaijers, T.M. Post, R. Schoemaker, M.N. Trame, Y. Xiong, W. Wang. Nonlinear Mixed-Effects Model Development and Simulation Using nlmixr and Related R Open-Source Packages. CPT Pharmacometrics Syst Pharmacol. 8 (2019) 621-633. https://doi.org/10.1002/psp4.12445.

J.G. Wagner, E. Nelson. Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single doses of drug. J Pharm Sci. 53 (1964) 1392-1403. https://doi.org/10.1002/jps.2600531126

J. Autmizguine, C. Melloni, C.P. Hornik, S. Dallefeld, B. Harper, R. Yogev, J.E. Sullivan, A.M. Atz, A. Al-Uzri, S. Mendley, B. Poindexter, J. Mitchell, A. Lewandowski, P. Delmore, M. Cohen-Wolkowiez, D. Gonzalez, the Pediatric Trials Network Steering Committee. Population Pharmacokinetics of Trimethoprim-Sulfamethoxazole in Infants and Children. Antimicrob Agents Chemother. 62 (2017) e01813-17. https://doi.org/10.1128/aac.01813-17

N. Alsaad, J.A. Dijkstra, O.W. Akkerman, W.C.M. De Lange, D. Van Soolingen, J.G.W. Kosterink, T.S. Van Der Werf, J.W.C. Alffenaar. Pharmacokinetic Evaluation of Sulfamethoxazole at 800 Milligrams Once Daily in the Treatment of Tuberculosis. Antimicrob Agents Chemother. 60 (2016) 942–3947. https://doi.org/10.1128/aac.02175-15

R. Welte, R. Beyer, J. Hotter, A. Broeker, S.G. Wicha, T. Gasperetti, P. Ranke, M.-M. Zaruba, I. Lorenz, S. Eschertzhuber, M. Ströhle, R. Bellmann-Weiler, M. Joannidis, R. Bellmann. Pharmacokinetics of trimethoprim/sulfametrole in critically ill patients on continuous renal replacement therapy. J Antimicrob Chemother. 75 (2020) 1237–1241. https://doi.org/10.1093/jac/dkz556

P.A. Masters, T.A. O’Bryan, J. Zurlo, D.Q. Miller, N. Joshi. Trimethoprim-Sulfamethoxazole Revisited. Arch Intern Med. 163 (2003) 402–410. https://doi.org/10.1001/archinte.163.4.402.